The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

That’s why empowering local voices within global teams is mission critical. It’s not just about having someone in the seat; ...